114 related articles for article (PubMed ID: 1355765)
1. Reference period analysis of vaginal bleeding with triphasic oral contraceptive agents containing norethindrone or levonorgestrel: a comparison study.
Schwarz BE; Pierce C; Walden CE; Knopp RH
Int J Fertil; 1992; 37(3):176-82. PubMed ID: 1355765
[TBL] [Abstract][Full Text] [Related]
2. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
Masson S; Franssen E; Hilditch JR; Powell MG
Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
[TBL] [Abstract][Full Text] [Related]
3. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
4. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
Edelman AB; Koontz SL; Nichols MD; Jensen JT
Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
[TBL] [Abstract][Full Text] [Related]
5. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
Westhoff C; Osborne LM; Schafer JE; Morroni C
Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622
[TBL] [Abstract][Full Text] [Related]
6. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
Teichmann A; Apter D; Emerich J; Greven K; Klasa-Mazurkiewicz D; Melis GB; Spaczynski M; Grubb GS; Constantine GD; Spielmann D
Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
[TBL] [Abstract][Full Text] [Related]
7. A clinical overview of a new triphasic contraceptive containing gestodene.
Christie T
Int J Fertil; 1989 Sep; 34 Suppl():40-9. PubMed ID: 2576257
[TBL] [Abstract][Full Text] [Related]
8. [A comparative clinical study of the effects of three types of low-dose estrogen/progestogen oral contraceptives].
Chen JK
Shengzhi Yu Biyun; 1987 May; 7(2):11-6. PubMed ID: 12268918
[TBL] [Abstract][Full Text] [Related]
9. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Belsey EM
Contraception; 1988 Aug; 38(2):181-206. PubMed ID: 2971505
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Witjaksono J; Lau TM; Affandi B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
[TBL] [Abstract][Full Text] [Related]
11. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
12. A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study.
Chavez A; DelConte A
Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):75-83. PubMed ID: 10427482
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
Archer DF; Jensen JT; Johnson JV; Borisute H; Grubb GS; Constantine GD
Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
[TBL] [Abstract][Full Text] [Related]
14. Biphasic versus triphasic oral contraceptives for contraception.
Van Vliet H; Grimes D; Helmerhorst F; Schulz K
Cochrane Database Syst Rev; 2001; (4):CD003283. PubMed ID: 11687185
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
Nakajima ST; Archer DF; Ellman H
Contraception; 2007 Jan; 75(1):16-22. PubMed ID: 17161118
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
18. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
Hampton RM; Zhang HF; Barnowski C; Wan GJ
Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
[TBL] [Abstract][Full Text] [Related]
19. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
[TBL] [Abstract][Full Text] [Related]
20. Three triphasic oral contraceptives now available in U.S.
Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
